These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 26994682)
21. Heparin-induced thrombocytopenia: when a low platelet count is a mandate for anticoagulation. Ortel TL Hematology Am Soc Hematol Educ Program; 2009; ():225-32. PubMed ID: 20008202 [TBL] [Abstract][Full Text] [Related]
22. The roles of anticoagulants in patients with cancer. Lee AY Thromb Res; 2010 Apr; 125 Suppl 2():S8-11. PubMed ID: 20434012 [No Abstract] [Full Text] [Related]
23. Prevention of catheter-related venous thrombosis with nadroparin in patients receiving chemotherapy for hematologic malignancies: a randomized, placebo-controlled study. Niers TM; Di Nisio M; Klerk CP; Baarslag HJ; Büller HR; Biemond BJ J Thromb Haemost; 2007 Sep; 5(9):1878-82. PubMed ID: 17723127 [TBL] [Abstract][Full Text] [Related]
24. Management of venous thromboembolism: Time to measure our performance. Tan MWY; Chunilal S; Mansfield D Respirology; 2018 Mar; 23(3):246-247. PubMed ID: 29336519 [No Abstract] [Full Text] [Related]
25. Drug-related thrombosis in hematologic malignancies. Nadir Y; Hoffman R; Brenner B Rev Clin Exp Hematol; 2004 Jun; 8(1):E4. PubMed ID: 16029970 [TBL] [Abstract][Full Text] [Related]
27. Cancer patients requiring interruption of long-term warfarin because of surgery or chemotherapy induced thrombocytopenia: the use of fixed sub-therapeutic doses of low-molecular weight heparin. Saccullo G; Malato A; Raso S; Santoro M; Zammit V; Casuccio A; Siragusa S Am J Hematol; 2012 Apr; 87(4):388-91. PubMed ID: 22374861 [TBL] [Abstract][Full Text] [Related]
28. Anticoagulant use in patients with cancer associated venous thromboembolism: a retrospective cohort study. Rahme E; Feugère G; Sirois C; Weicker S; Ramos E Thromb Res; 2013 Mar; 131(3):210-7. PubMed ID: 23290095 [TBL] [Abstract][Full Text] [Related]
29. Treatment of venous thromboembolism in cancer patients. Lee AY Best Pract Res Clin Haematol; 2009 Mar; 22(1):93-101. PubMed ID: 19285276 [TBL] [Abstract][Full Text] [Related]
35. Discriminative value of platelet size indices for the identification of the mechanism of chemotherapy-induced thrombocytopenia. ten Berg MJ; Huisman A; van den Bemt PM; den Breeijen H; Egberts TC; van Solinge WW Biomarkers; 2011 Feb; 16(1):51-7. PubMed ID: 20977409 [TBL] [Abstract][Full Text] [Related]
36. The gastrointestinal tract is a common target of invasive aspergillosis in patients receiving cytotoxic chemotherapy for hematological malignancy. Kami M; Hori A; Takaue Y; Mutou Y Clin Infect Dis; 2002 Jul; 35(1):105-6; author reply 106-7. PubMed ID: 12060886 [No Abstract] [Full Text] [Related]
38. Caelyx-induced unilateral erythrodysesthaesia secondary to venous thromboembolism. Merika EE; Gore M; Fearfield LA Eur J Dermatol; 2017 Jun; 27(3):321-322. PubMed ID: 28468742 [No Abstract] [Full Text] [Related]
39. Venous Thromboembolism in Patients With Thrombocytopenia: Risk Factors, Treatment, and Outcome. Baelum JK; Moe EE; Nybo M; Vinholt PJ Clin Appl Thromb Hemost; 2017 May; 23(4):345-350. PubMed ID: 26512063 [TBL] [Abstract][Full Text] [Related]
40. Management of venous thromboembolism in cancer patients and the role of the new oral anticoagulants. Wharin C; Tagalakis V Blood Rev; 2014 Jan; 28(1):1-8. PubMed ID: 24360911 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]